EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peptides for trans‐blood–brain barrier delivery

Reuben Blades, Lars M Ittner, Ole Tietz iD

Journal of Labelled Compounds and Radiopharmaceuticals · 2023-07 · 66 (9) · 237-248

DOI: 10.1002/jlcr.4023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 20.04.2023. Verfasst von Reuben Blades und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Au…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cell-Penetrating Peptides. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trans‐blood–brain barrier (BBB) delivery of therapeutic and diagnostic agents is a major challenge in the development of central nervous system (CNS) targeted radiopharmaceuticals. This review is an introduction to the use of peptides as delivery agents to transport cargos into the CNS. The most widely used BBB‐penetrating peptides are reviewed here, with a particular emphasis on the broad range of cargos delivered into the CNS using these. Cell‐penetrating peptides (CPPs) have been deployed as trans‐BBB delivery agents for some time; new developments in the CPP field offer exciting opportunities for the design of next generation trans‐BBB complexes. Many of the peptides highlighted here are ready to be combined with diagnostic and therapeutic radiopharmaceuticals to develop highly effective CNS‐targeted agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierCell-Penetrating PeptidesRadiopharmaceuticalsDrug Delivery SystemsBiological Transport

Stichwörter der Autor:innen

blood-brain barriercell penetrating peptidespeptidesradiopharmaceuticals

Substanzen

RadiopharmaceuticalsCell-Penetrating Peptides

Autor:innen und Institutionen

  • Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

ORCID-Profile: Ole Tietz

Förderung

  • National Health and Medical Research Council
  • Australian Research Council

Zitieren

APA

Blades, R., Ittner, L. M., & Tietz, O. (2023). Peptides for trans‐blood–brain barrier delivery. Journal of Labelled Compounds and Radiopharmaceuticals, 66(9), 237-248. https://doi.org/10.1002/jlcr.4023

Vancouver

Blades R, Ittner LM, Tietz O. Peptides for trans‐blood–brain barrier delivery. Journal of Labelled Compounds and Radiopharmaceuticals. 2023;66(9):237-248. doi:10.1002/jlcr.4023

BibTeX
@article{Blades2023,
  author = {Blades, Reuben and Ittner, Lars M and Tietz, Ole},
  title = {Peptides for trans‐blood–brain barrier delivery},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2023},
  volume = {66},
  number = {9},
  pages = {237--248},
  doi = {10.1002/jlcr.4023}
}
Kostenlos starten →